Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Rating of "Moderate Buy" from Brokerages

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has received an average recommendation of "Moderate Buy" from the eleven analysts that are covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $81.10.

Several brokerages have recently issued reports on HSIC. Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Mizuho assumed coverage on Henry Schein in a report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 target price for the company. Finally, Wells Fargo & Company started coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target on the stock.

Henry Schein Price Performance

Shares of Henry Schein stock traded down $0.78 during trading hours on Thursday, hitting $68.62. The company's stock had a trading volume of 1,028,798 shares, compared to its average volume of 1,573,330. The company has a market cap of $8.52 billion, a PE ratio of 28.24, a PEG ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The business has a 50 day moving average price of $74.62 and a two-hundred day moving average price of $72.60. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.49.

Remove Ads

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.66 earnings per share. Analysts expect that Henry Schein will post 4.74 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Pathstone Holdings LLC increased its position in shares of Henry Schein by 3.1% during the third quarter. Pathstone Holdings LLC now owns 24,028 shares of the company's stock worth $1,752,000 after purchasing an additional 732 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Henry Schein by 0.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company's stock worth $85,662,000 after acquiring an additional 6,184 shares in the last quarter. Cerity Partners LLC boosted its holdings in Henry Schein by 12.3% in the third quarter. Cerity Partners LLC now owns 26,339 shares of the company's stock worth $1,920,000 after acquiring an additional 2,894 shares in the last quarter. Daiwa Securities Group Inc. grew its stake in shares of Henry Schein by 11.4% during the third quarter. Daiwa Securities Group Inc. now owns 15,636 shares of the company's stock worth $1,140,000 after acquiring an additional 1,596 shares during the last quarter. Finally, Bank of Montreal Can raised its position in shares of Henry Schein by 365.6% in the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock valued at $52,095,000 after purchasing an additional 558,689 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.